MHRA Approval for Multi-Dose Clinical Trial

Tuesday, June 12th 2012

Print this page

MHRA_website_logo.jpgLast week the MHRA (Medicines and Healthcare Products Regulatory Agency) granted the final approval necessary for the main body of work in our planned clinical trial to begin.

 

With everything now in place, the first patient visits in London and Edinburgh will take place over the next week.

 

Due to the number of patients enrolled and the 12 visits/patient over 12 months, the trial has a staggered start and finish and will run until sometime in the first half of 2014.


 

E.coli from a large scale industrial production of our clinical trial plasmid pGM169.